back to the BIVI product listing
Description
Bovine Rhinotracheitis Vaccine Modified Live Virus. ® I contains neomycin as a preservative.
Features
- Contains IBR modified live virus.
- IBR fraction stimulates serological and cell mediated immune (CMI) response.
- One dose stimulates active immunity in healthy, susceptible cattle.
- Sub-Q administration; 2 mL dose.
Benefits
- Provides a proven efficacious immune response in healthy, susceptible cattle.
- Provides cattle with the capability to launch a serological and CMI response against an IBR challenge.
- Meets NCBA BQA guidelines.
- No milk withholding.
Advantages
Express I administration allows cattle to launch a serological and CMI response against an IBR challenge.
Dosage & Administration
Rehydrate one bottle of modified live virus vaccine by aseptically adding one bottle of liquid diluent. Using aseptic technique inject a 2 mL dose Sub-Q. Calves vaccinated before 6 months of age should be revaccinated at 6 months. A 2 mL booster dose is recommended annually.
Precautions
Store out of direct sunlight at 35∞ - 45∞ F (2∞ - 7∞ C). Avoid freezing. Shake well before using. Use entire contents when first opened. Do not vaccinate within 21 days of slaughter. Do not use in pregnant cows or in calves nursing pregnant cows. Burn containers and all unused contents. Injection site swelling may occur. Anaphylactoid reactions may occur.
Antidote: Epinephrine.
Antidote: Epinephrine.
Uses
Express I is recommended for vaccination of healthy, susceptible cattle as an aid in the reduction of disease caused by IBR.
Warning
Animal inoculation only. Accidental injection to humans can cause serious local reactions. Contact a physician immediately if accidental injection occurs.
Highlights
- Protects against IBR.
- IBR fraction stimulates a serological and CMI response.
- Use in cattle of all ages.
- One dose.
- Sub-Q administration; 2 mL dose.
Files
Ref PDF:
Label PDF:
MSDS PDF:
Additional Documents:
